Cargando…

Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy

Detalles Bibliográficos
Autores principales: Dumitrascu, Oana M., McKeon, Andrew, Zuniga, Leslie, Grill, Marie F., Goodman, Brent P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507190/
https://www.ncbi.nlm.nih.gov/pubmed/28740856
http://dx.doi.org/10.1212/NXI.0000000000000376
_version_ 1783249700094214144
author Dumitrascu, Oana M.
McKeon, Andrew
Zuniga, Leslie
Grill, Marie F.
Goodman, Brent P.
author_facet Dumitrascu, Oana M.
McKeon, Andrew
Zuniga, Leslie
Grill, Marie F.
Goodman, Brent P.
author_sort Dumitrascu, Oana M.
collection PubMed
description
format Online
Article
Text
id pubmed-5507190
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-55071902017-07-24 Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy Dumitrascu, Oana M. McKeon, Andrew Zuniga, Leslie Grill, Marie F. Goodman, Brent P. Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2017-06-26 /pmc/articles/PMC5507190/ /pubmed/28740856 http://dx.doi.org/10.1212/NXI.0000000000000376 Text en Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Clinical/Scientific Notes
Dumitrascu, Oana M.
McKeon, Andrew
Zuniga, Leslie
Grill, Marie F.
Goodman, Brent P.
Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
title Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
title_full Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
title_fullStr Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
title_full_unstemmed Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
title_short Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
title_sort opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy
topic Clinical/Scientific Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507190/
https://www.ncbi.nlm.nih.gov/pubmed/28740856
http://dx.doi.org/10.1212/NXI.0000000000000376
work_keys_str_mv AT dumitrascuoanam opsoclonusmyoclonussyndromeduringrituximabtreatmentforautoimmuneautonomicganglionopathy
AT mckeonandrew opsoclonusmyoclonussyndromeduringrituximabtreatmentforautoimmuneautonomicganglionopathy
AT zunigaleslie opsoclonusmyoclonussyndromeduringrituximabtreatmentforautoimmuneautonomicganglionopathy
AT grillmarief opsoclonusmyoclonussyndromeduringrituximabtreatmentforautoimmuneautonomicganglionopathy
AT goodmanbrentp opsoclonusmyoclonussyndromeduringrituximabtreatmentforautoimmuneautonomicganglionopathy